Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas
Cell and Gene Therapy CDMO Targets North American Growth With Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
Form Bio Selected by Google Cloud To Help Organizations Adopt New AI-Powered Life Sciences Solutions
Form Bio announced that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life science companies and academic institutions.
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
Waters™ Corporation has completed its acquisition of Wyatt Technology, a developer of innovative light scattering and field-flow fractionation instruments, software, accessories and services.
Efficient Transduction of CAR Into T Cells
AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
Form Bio Announces AI Solution Set for Predicting and Optimizing Cell and Gene Therapy Manufacturability
Form Bio has announced the launch of FORMsightAI, a new, AI-based solution set for predicting and optimizing manufacturing outputs of cell and gene therapy constructs.
Eppendorf Simplifies Bioprocess Data Acquisition
Eppendorf introduces the Bioprocess Autosampler, which facilitates sampling 24/7 in short and regular intervals, gaining complete datasets.